Trials / Sponsors / EuroCityClinic LLC
EuroCityClinic LLC
Network · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophospham Metastatic Non-small Cell Lung Cancer (NSCLC), Metastatic Cutaneous Melanoma | Phase 2 | 2025-08-14 |